Simizu S, Imoto M, Masuda N, Takada M, Umezawa K
Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.
Cancer Res. 1996 Nov 1;56(21):4978-82.
Tyrosine kinase inhibitor, erbstatin, induced morphological apoptosis and DNA fragmentation in human small cell lung carcinoma (SCLC) cells. Erbstatin-induced apoptosis was inhibited by antioxidants, whereas erbstatin-inhibited tyrosine phosphorylation was not affected by them. Erbstatin was shown by means of flow cytometry to induce hydrogen peroxide generation. Furthermore, hydrogen peroxide induced morphological apoptosis and DNA fragmentation in the SCLC cells. We also demonstrated that erbstatin-induced hydrogen peroxide production and DNA fragmentation were partially suppressed by inhibition of protein synthesis. Thus, erbstatin-induced apoptosis would be due to hydrogen peroxide generation via newly synthesized protein.
酪氨酸激酶抑制剂埃布他汀可诱导人小细胞肺癌(SCLC)细胞发生形态学凋亡及DNA片段化。抗氧化剂可抑制埃布他汀诱导的凋亡,而埃布他汀抑制的酪氨酸磷酸化不受其影响。流式细胞术显示埃布他汀可诱导过氧化氢生成。此外,过氧化氢可诱导SCLC细胞发生形态学凋亡及DNA片段化。我们还证明,抑制蛋白质合成可部分抑制埃布他汀诱导的过氧化氢生成及DNA片段化。因此,埃布他汀诱导的凋亡可能是由于通过新合成的蛋白质产生过氧化氢所致。